GALNT7 and thyroid gland carcinoma: In addition, during thyroid cancer progression, miR-30d-5p inhibits thyroid cancer progression by targeting GALNT7, and GALNT7 has been demonstrated to be a direct and functional target of miR-30b-5p [20].